Arcturus Therapeutics Leadership

Joseph E. Payne, is Founder, President, Chief Executive Officer and Chairman of the Board for Arcturus Therapeutics, Inc. He brings with him an exceptional track record of ushering novel therapeutics to the clinic including successful experience developing sophisticated targeted RNAi nanoparticle technologies. Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto Denko as evidenced by over 40 publications and patents, and 7 FDA-approved IND clinical candidates.

Experienced Chief Financial Officer and Board Of Director with a demonstrated history of raising capital and investing in the biotech, healthcare, medical device and technology industries. Strong business development professional skilled in asset management, contract negotiations, mutual funds, financial structuring and valuation analysis.

Joseph E. Payne, is Founder, President, Chief Executive Officer and Chairman of the Board for Arcturus Therapeutics, Inc. He brings with him an exceptional track record of ushering novel therapeutics to the clinic including successful experience developing sophisticated targeted RNAi nanoparticle technologies. Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto Denko as evidenced by over 40 publications and patents, and 7 FDA-approved IND clinical candidates.

Joseph E. Payne, is Founder, President, Chief Executive Officer and Chairman of the Board for Arcturus Therapeutics, Inc. He brings with him an exceptional track record of ushering novel therapeutics to the clinic including successful experience developing sophisticated targeted RNAi nanoparticle technologies. Joseph’s background includes over 20 years of successful drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto Denko as evidenced by over 40 publications and patents, and 7 FDA-approved IND clinical candidates.

Experienced Chief Financial Officer and Board Of Director with a demonstrated history of raising capital and investing in the biotech, healthcare, medical device and technology industries. Strong business development professional skilled in asset management, contract negotiations, mutual funds, financial structuring and valuation analysis.

Steve Hughes is a Chief Medical Officer at ARCTURUS THERAPEUTICS LTD. and President at Iatrogenic Solutions and is based in San Diego, California. He has worked as VP, Head of Clinical Development at IONIS PHARMACEUTICALS INC; Medical Affairs Manager at SANOFI; and Chief Clinical Development Officer at IONIS PHARMACEUTICALS INC. Steve studied at Esher College etc and Imperial College London between 1995 and 2001.